https://www.newswire.ca/news-releases/affinium-pharmaceuticals-announces-positive-efficacy-safety-and-tolerability-results-from-phase-2a-clinical-trial-of-oral-afn-1252-in-acute-bacterial-skin--skin-structure-infections-512109421.html
Affinium Pharmaceuticals Announces Positive Efficacy, Safety, and Tolerability Results from Phase...
safety and tolerabilityresults frompharmaceuticalsannouncespositive